What's new

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised

Apr 26, 2025 - 14:24
 0
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised
Read More

Tags:

Previous Article

Procurement

Next Article

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, ...

Related Posts

EMEA-002282-PIP01-17-M02

EMEA-002282-PIP01-17-M02

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0

Human medicines European public assessment report (EPAR): Micardis, telmisartan, Date of authorisation: 16/12/1998, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0